Jump to:
Alexandra Charron is an associate in Ropes & Gray’s corporate department, where her practice centers on mergers and acquisitions. She represents both public and private multinational companies in a broad range of complex domestic and cross-border transactions and governance matters, including mergers and acquisitions, stock and asset purchases, global divestitures, capital markets transactions and venture investments as well as other strategic transactions. Alexandra also regularly advises investment banks on financial advisory engagements and counsels venture backed and private equity portfolio companies on ongoing corporate and commercial matters. Her industry experience spans pharmaceutical, technology, life sciences, biotech, consumer products, fintech, travel and hospitality industries, among others.
Experience
- Advised Gilgamesh Pharmaceuticals in an agreement to sell its lead investigational candidate, bretisilocin, to AbbVie for up to $1.2 billion, inclusive of an upfront payment and development milestones. Bretisilocin is a potential best-in-class psychedelic compound for the treatment of patients with moderate to severe major depressive disorder.
- Represented Sanofi in acquisition of Dren Bio’s bispecific antibody-based program in immunology deal worth up to $1.9 billion.
- Represented Simple Mills in its $795 million sale to Flowers Foods.
- Represented a global pharmaceutical company in its investment and partnership with a Chinese biotech company, with potential aggregate proceeds in excess of $3 billion.
- Represented Regeneron in acquisition of 2seventy Bio, Inc.’s platforms to form new R&D unit Regeneron Cell Medicines.
- Represented Johnson & Johnson’s pharmaceuticals business, Janssen Pharmaceuticals, in connection with various domestic and cross-boarder divestitures of pharmaceutical businesses.
- Represented TravelCenters of America Inc. in its $1.3 billion sale to BP p.l.c.
- Represented MACOM Technology Solutions Holdings, Inc. in its acquisition of Linearizer Communications Group, a developer of high-performance microwave photonic solutions with avionic and space-based applications.
- Represented Ginkgo Bioworks in connection with various life sciences acquisitions including its collaboration and carve-out transaction from Bayer AG to build an agricultural biologicals research & development platform and its acquisition of Proof Diagnostics.
- Represented a leader in data driven precision medicine in its acquisition of an artificial intelligence medical imaging company.
- Represented a leading medical technology company in connection with numerous acquisitions of medical technology and device companies.
- Represented a U.S. “buy now, pay later” (“BNPL”) platform in its agreement to be acquired by a leading global BNPL provider.
- Represented Crosspoint Capital Partners in its investment in Afero, a leading provider of an Internet of Things Platform as a Service.
- Represents a number of investment banks in their capacity as financial advisors on a variety of M&A transactions including the following recent transactions:
- International Game Technology PLC’s pending sale of its Global Gaming and PlayDigital businesses to Apollo Global Management, Inc. (and prior transaction pursuant to which such business would have been merged with Everi Holdings).
- Sale of Akoya Biosciences to Quanterix.
- Acquisition of United Development Funding IV by Ready Capital Corporation.
- Atlantic Union Bancshares’ $1.6 billion acquisition of Sandy Spring Bancorp.
- Sale of The Shyft Group to Aebi Schmidt Holding.
- Tadano’s acquisition of Manitex International.
- CommScope’s $2.1 billion sale of its distributed antennas system business and outdoor wireless networks business to Amphenol Corporation.
- Sale of majority stake in Grant Thornton to an affiliate of New Mountain Capital.
- Victory Capital Holdings, Inc.’s pending acquisition of the U.S. business of Amundi.
- Acquisition by Golub Capital BDC, Inc. of Golub Capital BDC 3, Inc.
- Wyndham Hotels & Resorts’ defense of an unsolicited takeover proposal by Choice Hotels International Inc.
- Acquisition by Conn’s Inc. of W.S. Badcock.
- Wintrust Financial Corporation’s acquisition of Macatawa Bank Corporation.
- Sale of Aveo Pharmaceuticals to LG Chem Ltd.
- Take-private sale of Chase Corporation to KKR for $1.3 billion.